Prospects and challenges for use of CAR T cell therapies in solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prospects and challenges for use of CAR T cell therapies in solid tumors

Published:2020-03-12 Issue:5 Volume:20 Page:503-516
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Ramakrishna Sneha¹,Barsan Valentin¹,Mackall Crystal¹²³

Affiliation:

1. Department of Pediatrics, Bass Center for Childhood Cancer and Blood Disorders, Center for Cancer Cell Therapy, Stanford, USA

2. Stanford Cancer Institute, Stanford University, Stanford, USA

3. Department of Medicine, Stanford University, Stanford, USA

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1738378

Reference142 articles.

1. CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia

2. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

3. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

4. Anti-BCMA CAR T cells show promise in MM

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in CAR-NK cell therapy for hematological malignancies;Frontiers in Immunology;2024-06-28

2. Acellular scaffold-based approach for in situ genetic engineering of host T-cells in solid tumor immunotherapy;Military Medical Research;2024-01-04

3. Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy;Cancer Cell;2024-01

4. Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing;Journal of Leukocyte Biology;2023-12-27

5. Stat5 opposes the transcription factor Tox and rewires exhausted CD8+ T cells toward durable effector-like states during chronic antigen exposure;Immunity;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3